PHARMA | PHARMANIAGA BHD

8 8
0.805 (-0.62%)

T-O: 0.815 (08:59:00)
Last updated: 17:00

Fundamental   4.1  
Technical   1.1  
Total Score   5.2  

 Insti+ 
PHARMA | PHARMANIAGA BHD


Fundamental

iSaham Fundamental Trend

FCON: 0.43 | Sharpe Ratio: 0.2 | LTS: 4.78


Quarter Reports

Trailing Dividend

Financial Ratios

EPS 2.44 sen
Trailing PE (Sector Median: 24.4) 33.0
PEG 0.33
Altman Z 1.2
Beaver -0.191
Current Ratio 0.93
Debt-Equity (DE) Ratio 5.74
FCF Yield -40.42 %
Revenue QoQ 82.28 %
Revenue YoY 11.45 %
Profit QoQ 37.33 %
Profit YoY 121.92 %
All-Time Profit Margin (Sector Median: 2.1) 3.3 %
ROE (ROIC: 6.47) 8.46 %
Dividend Per Share (DPS) 8.0 sen
Dividend Yield (DY) 9.94 %

Fair Value

Weighted Average Fair Value: 1.23

Discounted Cash Flow (DCF) 5% Growth 0.235
Discounted Cash Flow (DCF) 10% Growth 0.31
Relative Valuation 0.595
Average Analysts FV based on 4 rating(s), +132.3% 1.87
Graham Formula 0.815
Graham Number 1.87
Net Tangible Asset (NTA) 0.27
Consistent QR FV N/APremium Access Only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit 14.44
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 330.12
Expected Revenue (M) 31439.92
Expected Growth (%) 38.0

Directors Share Purchases (Beta)


No transaction in the last 2 months.

Technical

Summary

Market Cap: 1054 M.

Number of Shares: 1309 M.

Adjusted Float: 33.0%.

Stock highly correlated with

DPHARMA (92%)

TGUAN (89%)

BIOHLDG (86%)

NICE (86%)

Manipulation Indicator: Very hard to manipulate.

Pharmaniaga Berhad, through its subsidiaries, operates as an integrated healthcare company. It is engaged in the logistics and distribution; sale and marketing; and research, development, and manufacture of generic pharmaceuticals, as well as the supply of medical products and services; hospital equipping; and provision of information technology solutions. It is also involved in the sale and distribution of portable medical devices; contract manufacturing; and distribution and trade of pharmaceuticals products, food supplements, and diagnostics products. Pharmaniaga sells its products and services to the public and private sectors primarily in Malaysia and Indonesia. The company was founded in 1994 and is based in Shah Alam, Malaysia. Pharmaniaga Bhd operates as a member of UEM Group.

Sectors: Trading & Services, Healthcare, Medical Service & Equipment, Pharmaceuticals, Budget 2021, Post MCO, Vaccine, Politic Related

Code: 7081

Website: http://www.pharmaniaga.com/

Related Links: Bursa | Annual Report | Announcement

Top Shareholdings

Updated on 3-May-2021

Shareholder Value (M)
Boustead Holdings Berhad 117.62
Lembaga Tabung Angkatan Tentera 23.53
Great Eastern Life Assurance (Malaysia) Berhad 4.66
Dasar Technologies Sdn Bhd 1.58
Syarikat Takaful Malaysia Keluarga Berhad 1.58
Che Lodin Bin Wok Kamaruddin 1.26
Kumpulan Wang Persaraan (Diperbadankan) 0.97
Citigroup Nominees (Asing) Sdn Bhd UBS AG 0.78
Chinchoo Investment Sdn. Berhad 0.74
Employees Provident Fund Board 0.65
Yong Siew Yoon 0.65
Gibraltar BSN Aggressive Fund 0.61
Gan Teng Siew Realty Sdn. Berhad 0.53
Vathivaloo A/L A.S Ramaiah 0.53
Yayasan LTAT 0.48
UOB Kay Hian Pte Ltd 0.44
Tan Heng Loon 0.42
Key Development Sdn. Berhad 0.42
Venudran A/L Raman 0.38
Fong Ming Sang 0.38
Gemas Bahru Estates Sdn. Bhd. 0.36
Bidor Tahan Estates Sdn.Bhd. 0.32
Mikdavid Sdn Bhd 0.29
Yeo Ann Seck 0.29
PMB Shariah Dividend Fund 0.27